(RTTNews) - Merck KGaA (MKGAY.PK), a German science and technology ... year guidance to reflect the impact of the current macro-economic and geopolitical environment. The company added that ...

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference ... was characterized by a rapidly changing global economic landscape to say the least, and we delivered very ...

Technologycategory· August 1, 2024 Merck raises outlook for electronics and healthcare, sees improved chip market demand Merck KGaA is seeing ... provides business, financial, national and ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

US job openings in research and development are plunging as the Trump administration ramps up funding cuts to government agencies, private contractors and universities, leaving some of the nation’s ...

Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and foreign ...

US job openings in research and development are plunging as the Trump administration ramps up funding cuts to government ...

European shares slipped on Thursday, dragged by energy stocks, while investors awaited key economic data and remarks from U.S ...

German pharmaceutical and specialty materials group Merck KGaA fell 6% after it guided more cautiously for 2025 earnings, citing the macro-economic and geopolitical environment as well as foreign ...

Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt ... today announced its financial results for the first quarter ended March 31, 2025 ...

Merck KGaA, the German science and technology group ... The new guidance reflects an uncertain macro-economic and geopolitical environment and foreign-exchange effects that may weigh on all three ...

MELBOURNE, Australia, May 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces a strong presence at the 55th Annual Scientific Meeting ...